RESEARCH MONOGRAPH · KDC-MN-115

Schisandra chinensis

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

67/100

Lignans are real chemistry, hepatoprotection literature is decent, the adaptogen claims are mostly modest

Schisandra is the Chinese magnolia vine berry adaptogen, traditionally one of the "five-flavor" herbs (the Chinese name wu wei zi reflects that the berries hit sweet, sour, bitter, salty, and pungent). The modern interest is mostly around the schisandra lignans, a structurally distinctive family of dibenzocyclooctadiene compounds with schisandrin A, B, C and gomisin A among the most-studied. The chemistry is genuinely well-mapped at this point.

The hepatoprotection literature is the strongest part of the modern schisandra story. Multiple Chinese and Russian studies have shown protective effects against various hepatotoxins in animal models, with mechanism work pointing toward CYP induction, glutathione preservation, and direct antioxidant activity. Some small human trials in viral hepatitis and chemical liver damage cohorts have shown ALT and AST improvements, though the trials are mostly small and methodologically variable.

The cognitive and adaptogenic endpoints are thinner. There are small Russian trials going back to the Soviet adaptogen-research era showing performance benefits under fatigue and stress, but they havent been well-replicated to modern RCT standards. The traditional Chinese use as a sleep, calming, and yin-tonifying herb maps awkwardly onto modern endpoint thinking.

Mechanistically schisandrin B has demonstrated effects on glutathione system upregulation (NRF2 pathway induction), modest CYP3A4 modulation (which has interaction implications), and some glucocorticoid-receptor activity that could underpin the "stress modulation" framework. Schisandra-based prescription drugs (Bicyclol, derived from schisandrin C) are actually approved hepatoprotective agents in China, which is unusual for an adaptogen-class herb.

What we like: well-characterized lignan chemistry, real hepatoprotection signal in animal models, some human translation in liver-injury contexts, and the unusual fact that schisandra lignans gave rise to an approved Chinese pharmaceutical. That kind of validation doesn't happen often for adaptogen-category herbs.

What we dont like is the gap between the hepatoprotection literature and the more general cognitive/stress claims that dominate Western marketing. The interesting science is in the liver work and to a lesser extent the NRF2 stress-response work, not in adaptogen vibes.

Sourcing: schisandra berry extract standardized to total schisandrin content is the reasonable choice. Pure schisandrin B or A is available as research-grade material for mechanism work, HPLC 98%+ is achievable. The whole-berry preparations have a different chemistry than the lignan-isolated fractions.

Underrated for the liver chemistry, slightly overhyped for the general adaptogen claims.

Evidence: 55
Mechanism: 65
Reliability: 60
Safety: 82
Sourcing: 72
Value: 75
Signal: 60
Staying power: 65

Plain-language summary Intrigue 48 / 100

Schisandra (Chinese magnolia vine) berry is an adaptogen used in traditional Chinese medicine for stress, fatigue, and liver support. The lignans class drives the activity. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Chinese magnolia vine berry adaptogen

A Chinese berry traditionally used as the 'five flavors fruit' for endurance, mental clarity, and hepatoprotection, characterized by schizandrins.

Abstract

Schisandra chinensis (Wu Wei Zi, "five flavors fruit") is a climbing vine from China and Russia whose berries have been used for endurance, mental clarity, hepatoprotection, and longevity. The active constituents are lignans called schizandrins (schizandrin, gomisin A, gomisin N, and others). Modest hepatoprotective effects in liver injury models, antioxidant effects, and stress-tolerance effects have been documented. The schizandrins are CYP3A inducers, which has clinical drug interaction implications. Reported research dose ranges in the literature use berry extract.

Mechanism of action

Schizandrin lignans with hepatoprotective and antioxidant effects. CYP3A induction.

Reported research dose ranges

Reported research dose ranges in the literature describe berry extract quantities.

References

Panossian A, Wikman G. Pharmacology of Schisandra chinensis. J Ethnopharmacol 2008.

Read the full monograph

The full reference document covers compound identification, discovery and developmental history, mechanism of action, pharmacokinetics, reported research dose ranges, sourcing and quality verification, reconstitution and handling, stack interaction considerations, and a curated reference list. Available as a research-use-only PDF download.

KDC-MN-115

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Schisandra chinensis

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs